TNF Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
24 Aug 23 | BuyUS$166,500 | Paul Rivard | Individual | 5,000 | US$33.30 | |
17 Aug 23 | BuyUS$28,080 | Paul Rivard | Individual | 833.33 | US$33.70 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 3,459 | 0.146% |
Institutions | 66,517 | 2.81% |
Individual Insiders | 198,110 | 8.36% |
General Public | 2,102,337 | 88.7% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 79.6%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
124,815 | US$218.4k | 0% | no data | |||
68,295 | US$119.5k | 0% | no data | |||
30,657 | US$53.6k | -36.9% | no data | |||
9,707 | US$17.0k | 0% | no data | |||
6,802 | US$11.9k | -0.98% | no data | |||
6,248 | US$10.9k | 0.02% | 0.47% | |||
5,718 | US$10.0k | 0% | no data | |||
5,000 | US$8.7k | 0% | no data | |||
3,459 | US$6.1k | 0% | no data | |||
2,022 | US$3.5k | 2,370% | no data | |||
1,637 | US$2.9k | 0% | 100.0% | |||
999 | US$1.7k | 0% | no data | |||
838 | US$1.5k | 0% | no data | |||
459 | US$803.1 | -0.43% | no data | |||
247 | US$432.2 | 0.41% | no data | |||
224 | US$392.0 | -38% | no data | |||
167 | US$292.5 | 0.6% | no data | |||
167 | US$292.5 | 0.6% | no data | |||
116 | US$202.8 | 0% | no data | |||
99 | US$173.4 | 241% | no data | |||
90 | US$157.6 | 1.12% | no data | |||
90 | US$157.6 | 0% | no data | |||
39 | US$68.4 | 1,850% | no data | |||
34 | US$59.3 | 0% | no data | |||
34 | US$59.3 | 0% | no data |